Pharmaceutical
February 28, 2008
The Associated Press is reporting that Barr Pharmaceuticals has reached a $6 million settlement with 34 states that sued the company for illegally blocking the sale of a lower-priced
Read More
February 11, 2008
According to the Associated Press, a sales manager who "just couldn''t abide" by the way Merck wanted him to market the drugs Vioxx and Zocor to doctors took the lonely
Read More
January 16, 2008
Drug maker Cephalon Inc. reported recently its plans to close a facility in Eden Prairie, Minn., and consolidate other research and development activities, resulting in the elimination of about 90
Read More
January 14, 2008
Drug developer Pfizer Inc. said recently the U.S. Patent & Trademark Office rejected the company''s claim to a basic patent covering the blockbuster cholesterol drug Lipitor, but the treatment will
Read More
January 10, 2008
The Associated Press reported recently that Tyson Foods Inc. has reached an agreement with the U.S. Department of Agriculture over the antibiotics labels on its fresh chicken after federal officials
Read More
November 12, 2007
The Assoicated Press reports that Merck & Co. will pay $4.85 billion to end thousands of state and federal lawsuits over its painkiller Vioxx in one of the largest drug
Read More
November 5, 2007
A U.S. judge has ordered pharmaceutical companies AstraZeneca and Bristol-Myers Squibb Co. to pay double damages in a case over false mark ups of U.S. drug prices through 2003, according
Read More
October 22, 2007
Merck & Co. posted a 62 percent increase in its third-quarter profit as the drugmaker''s revenues increased by double digits, while lower administration and overhead costs offset more spending on
Read More
October 12, 2007
A lawsuit filed by Iowa Attorney General Tom Miller alleges that drug companies inflated prices of prescription drugs by millions of dollars causing state and federal governments to overpay for
Read More
October 8, 2007
According to the Associated Press, GlaxoSmithKline PLC has selected the president of its European pharmaceuticals division, Andrew Witty, to succeed Jean-Pierre Garnier as its chief executive officer. Witty, 43, who
Read More